Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by FabulousFabQc01

T.ATRL

RE:almost funny

Pas une premiere lors de la semaine d'expiration des options. J'en ai...

June 23, 2024

T.ATRL

Price Target Raised to C$68.00/Share From C$65.00 by Desjard

Price Target Raised to C$68.00/Share From C$65.00 by Desjardins Securities

May 16, 2024

T.ATRL

Price Target Raised to C$67.00/Share From C$66.00 by Scotia

Price Target Raised to C$67.00/Share From C$66.00 by Scotiabank

May 16, 2024

T.ATRL

Price Target Raised to C$65.00/Share From C$63.00 by RBC

Price Target Raised to C$65.00/Share From C$63.00 by RBC Capital

May 16, 2024

T.ATRL

RE:RE:RE:RE:Looking good

j'ai ajout hier

May 16, 2024

T.ATRL

RE:Desjardins Solid 1Q24 results with impressive organic growth

I might be wrong... but personnaly I don't think todays market reaction...

May 15, 2024

T.ATRL

Desjardins Solid 1Q24 results with impressive organic growth

ATRL reported healthy 1Q24 results. Although adjusted PS&PM core EBITDA...

May 15, 2024

T.ATRL

RE:RE:Time to sell

56 ce sera mon prix pour une partie de mes actions.. je vais laisse le march...

March 7, 2024

T.ATRL

RE:Outsized position

Fou le camp 

March 3, 2024

T.ATRL

Another big win in Saudi Arabia!

The comeback of SNC in Saudi Arabia could be an incredible catalyst. ...

June 7, 2023

T.POW

RE:Perte de 88% de l'action de Lion peu après son émission

pas si certain... ils ont bel et bien tent de vendre Lion, mais ca n'a...

May 17, 2023

T.POW

TD Raised to Buy From Hold

BUY with a new price target: $41 up from $38 :) 

May 17, 2023

T.ATRL

RE:RE:Finalstep, where are you ?

I tracked some of his moves and I'm not sure if he really made any money....

May 9, 2023

T.ATRL

analysts?

Are we going to see an analyst with a price target at $50? 

May 9, 2023

T.ATRL

RE:RE:RE:10% pop yoday

and No LSTK surprise:) 

May 9, 2023

T.ATRL

RE:Empirical evidence .. FWIW

Quel devin! C'est top enligne avec Tom Lee. 

March 28, 2023

T.ATRL

RE:1.8m + 2.7m shares sold short.

Hope we ere not the only ones seeing this. Such a big opportunity for a major...

March 7, 2023

T.ATRL

RBC: another price target raised from $36 to $39

RBC: another price target raised from $36 to $39

March 6, 2023

T.ATRL

Bastien: might be the better one to own over the next 12 m

   SNC-Lavalin will likely pique investor interest once the...

March 6, 2023

T.ATRL

RE:Share price increase on day of ER?? WOW!

Excellent points guys. Hope you're all right! I'm all in with SNC!

March 6, 2023

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next

Featured Company

NurExone Biologic Inc.

NurExone Biologic Inc. V.NRX

NurExone Biologic Inc. is a biopharmaceutical company. The Company is developing and commercializing an exosome therapy ... view more »